NOTE: By submitting this form and registering with us, you are providing us with permission to store your personal data and the record of your registration. In addition, registration with the Medical Independent includes granting consent for the delivery of that additional professional content and targeted ads, and the cookies required to deliver same. View our Privacy Policy and Cookie Notice for further details.

You can opt out at anytime by visiting our cookie policy page. In line with the provisions of the GDPR, the provision of your personal data is a requirement necessary to enter into a contract. We must advise you at the point of collecting your personal data that it is a required field, and the consequences of not providing the personal data is that we cannot provide this service to you.

Don't have an account? Subscribe

Pharma pays over €8m to healthcare organisations

By Catherine Reilly - 03rd Feb 2020

Healthcare organisations, including hospitals, were provided with over €8 million in funding by the pharmaceutical industry in 2018, according to figures compiled by the Medical Independent.

The payments are listed on the pharmaceutical company pages within the transfer of value (ToV) register, which was established by the Irish Pharmaceutical Healthcare Association (IPHA).

The organisations include public hospitals, clinical societies, membership colleges and faculties, and hospital foundations.

Higher-end payments to hospitals noted by MI across the 44 company pages on the ToV register included €74,090 from Gilead and €63,229 from Janssen to the Mater Misericordiae University Hospital (MMUH), Dublin; €93,314 from Sanofi to the Tallaght University Hospital (TUH) cardiology department and €64,000 to TUH from Takeda; and €58,741 from Daiichi Sankyo and €85,686 from Novartis to Beaumont Hospital, Dublin. All of the above hospitals were contacted to provide further details on the purpose of the funding.

A TUH spokesperson said: “With regard to the sums that you referenced TUH received €93,314 from Sanofi into the TUH bank account. This project was supported by the hospital and the cardiology department led by Prof Vincent Maher. The funding was to support the establishment of the Familial Hypercholesterolemia (FH) National Network. All of the funds were used to support medical hours and nursing hours to carry out the research. 

“The €64,000 from Takeda was received by a research account with an address at TUH. TUH is named as the healthcare organisation with an address at TUH. The hospital only has governance over funds which are transferred into the hospital’s bank account so cannot comment.”

A spokesperson for MMUH said the cited payments “are disclosure of payments made to individuals for research and development, donations and grants (including medical education and unrestricted educational grants), consultancy fees, registration fees or travel costs to attend medical conferences.  These payments may have been made to an individual, or a service, within the Mater Misericordiae University Hospital.”

No comment had been received from Beaumont Hospital by press time.

Leave a Reply

Latest Issue
The Medical Independent 26th September 2023

You need to be logged in to access this content. Please login or sign up using the links below.

Most Read